Vidya Ramakrishnan, PhD.

Principal Scientist
Genentech, Inc.

Poster(s):

• (S-034) Pharmacometric analysis of pharmacokinetics, safety, and efficacy data of migoprotafib in combination with divarasib for KRAS G12C-positive non-small cell lung cancer.
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT